USFDA APPLICATION NUMBER - 20929 / DOSAGE - SUSPENSION;INHALATION - 0.5MG/2ML
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X) | BUDESONIDE | 0.5mg in 2 |
Inactive Ingredients
Ingredient Name | Cardinal Health | The Ritedose Corporation | A-S Medication Solutions | Actavis Pharma, Inc. | American Health Packaging | Amneal Pharmaceuticals of New York LLC | Catalent Pharma Solutions, LLC | Cipla USA Inc. | Exelan Pharmaceuticals, Inc. | NorthStar RxLLC | Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals, Inc. | Apotex Corp. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANHYDROUS CITRIC ACID(XF417D3PSL) | |||||||||||||
CITRIC ACID MONOHYDRATE(2968PHW8QP) | |||||||||||||
EDETATE DISODIUM(7FLD91C86K) | |||||||||||||
polysorbate 80(6OZP39ZG8H) | |||||||||||||
SODIUM CHLORIDE (451W47IQ8X) | |||||||||||||
SODIUM CHLORIDE(451W47IQ8X) | |||||||||||||
SODIUM CITRATE(1Q73Q2JULR) | |||||||||||||
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | |||||||||||||
trisodium citrate dihydrate(B22547B95K) | |||||||||||||
WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?